QNTM
Quantum BioPharma Ltd
Chart
Technical data
$2.97
-0.67%
$0.21
4
$3.28 (-9.6%)
$4.48 (-33.7%)
$6.18 (-51.9%)
$4.69 (-36.7%)
$31.91 (-90.7%)
$2.07 (+43.5%)
282.28K
0.53
2026-07-27
18
Declining
500
-71.20%
-10.24%
-18.60%
0.57
1
99%
363
1254
2026-08-03
$3.45
5
2026-07-27
Upcoming confluences
| Date | Price | Score | Price levels | Time levels |
|---|---|---|---|---|
| 2026-08-10 | $3.45 | 2 | 5 | 9 |
| 2026-08-10 | $3.81 | 2 | 4 | 9 |
Fundamental data
Quantum BioPharma Ltd
Healthcare
Biotechnology
$20.99M
$1.19M
5.69M
—
6.10%
0.96
-54.63%
-81.16%
—
4
—
Fundamental analysis
No analysis yet. This will pull the latest 10-K, 10-Q, and DEF 14A from SEC EDGAR, ingest the company's XBRL financial facts, compute Beneish / Altman / Piotroski / Sloan / Penman–Nissim, run Greenwald EPV + Mauboussin reverse-DCF, and synthesise a Columbia-style moat, earnings quality, and capital allocation review. Cached for 90 days.
News (2)
| Published (UTC) | Session | Sentiment | Category | Move % | Headline |
|---|---|---|---|---|---|
| 2026-07-20 19:00 | Regular |
Bullish |
DebtRepayment |
-6.17% | Quantum BioPharma Announces Intention to Settle Debt |
| 2026-07-15 14:45 | Regular |
Bullish |
StrategicPlan |
-2.58% | Quantum BioPharma (QNTM) Expands Clinical Development of Neuroprotective Therapy |
SEC Filings (0)
No SEC filings cached for CIK 1771885 yet — run a fundamental analysis to import the last 3 years.
Beneficial Ownership 5%+ (0)
No SC 13D / 13G filings parsed for this symbol in the last 2 years.
Institutional Holders (0)
CUSIP not yet known for QNTM. Three population pathways: (1) the next fundamental analysis run extracts it from any SC 13D/G cover page filed against QNTM (cover pages print the subject-company CUSIP near the top); (2) the daily Form13FIngestionJob auto-links from a 13F-HR holding whose IssuerName uniquely matches QNTM's CompanyName; (3) manual SQL update on the Tickers row. Once linked, institutional holders appear below.
Current setups (0)
No open or triggered setups for QNTM right now.